Abiopharma

🔍 Simson Jake (Executive)

Company: Septerna, Inc. (SEPN)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 15,000 shares of Stock Option (Right to Buy) at $37.34 per share (Derivative)
  Date: 2026-06-26 | Code: A | Expires: 2036-06-25 | equity_swap_involved: false | shares_owned_after: 15,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The shares underlying the stock option vest in full upon the earlier of (i) June 26, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.
• F2: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the R.A. Capital Healthcare Fund, L.P. (the "Fund") and R.A. Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund III to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
• REMARKS: Exhibit 24.2 - Substitute Power of Attorney